# FDA Inspection 1325140 - Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. - June 16, 2026

Source: https://www.keypedia.com/records/fda_inspections/luoxin-aurovitas-pharma-chengdu-co-ltd/ccee6efc-4f3d-4190-9b5f-5ef838e8f18d
Source feed: FDA_Inspections

> FDA Inspection 1325140 for Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. on June 16, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1325140
- Company Name: Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.
- Inspection Date: 2026-06-16
- Product Type: Human Drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1218133 - 2023-08-11](https://www.keypedia.com/records/fda_inspections/luoxin-aurovitas-pharma-chengdu-co-ltd/b1b6efc0-b20c-43c0-a541-c14c0e727c34)

Company: https://www.keypedia.com/companies/luoxin-aurovitas-pharma-chengdu-co-ltd/699907d7-f2d0-481a-85a6-c1c17f69c630

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8